123 related articles for article (PubMed ID: 1325886)
1. Effect of neutral endopeptidase inhibitor in rats with congestive heart failure.
Murohara Y; Johnston CI
Clin Exp Pharmacol Physiol; 1992 May; 19(5):380-3. PubMed ID: 1325886
[TBL] [Abstract][Full Text] [Related]
2. Prolonged neutral endopeptidase inhibition in heart failure.
Helin K; Tikkanen I; Tikkanen T; Saijonmaa O; Sybertz EJ; Vemulapalli S; Sariola H; Fyhrquist F
Eur J Pharmacol; 1991 May; 198(1):23-30. PubMed ID: 1655477
[TBL] [Abstract][Full Text] [Related]
3. Elevation of plasma atrial natriuretic peptide in rats with chronic heart failure by SCH 39370, a neutral metalloendopeptidase inhibitor.
Tikkanen I; Helin K; Tikkanen T; Sybertz EJ; Vemulapalli S; Sariola H; Näveri H; Fyhrquist F
J Pharmacol Exp Ther; 1990 Aug; 254(2):641-5. PubMed ID: 2143536
[TBL] [Abstract][Full Text] [Related]
4. Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure.
Rademaker MT; Charles CJ; Kosoglou T; Protter AA; Espiner EA; Nicholls MG; Richards AM
Am J Physiol; 1997 Nov; 273(5):H2372-9. PubMed ID: 9374774
[TBL] [Abstract][Full Text] [Related]
5. Neutral endopeptidase inhibition: augmented atrial and brain natriuretic peptide, haemodynamic and natriuretic responses in ovine heart failure.
Rademaker MT; Charles CJ; Espiner EA; Nicholls MG; Richards AM; Kosoglou T
Clin Sci (Lond); 1996 Sep; 91(3):283-91. PubMed ID: 8869410
[TBL] [Abstract][Full Text] [Related]
6. Concurrent neutral endopeptidase and ACE inhibition in experimental heart failure: renal and hormonal effects.
Helin K
Scand J Clin Lab Invest; 1993 Dec; 53(8):843-51. PubMed ID: 8140395
[TBL] [Abstract][Full Text] [Related]
7. Acute hemodynamic, hormonal, and renal effects of neutral endopeptidase inhibition in ovine heart failure.
Fitzpatrick MA; Rademaker MT; Charles CJ; Yandle TG; Espiner EA; Ikram H; Sybertz E
J Cardiovasc Pharmacol; 1992 Apr; 19(4):635-40. PubMed ID: 1380608
[TBL] [Abstract][Full Text] [Related]
8. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
Kukkonen P; Vuolteenaho O; Ruskoaho H
Endocrinology; 1992 Feb; 130(2):755-65. PubMed ID: 1531129
[TBL] [Abstract][Full Text] [Related]
9. Comparison of chronic neutral endopeptidase inhibition and furosemide in an ovine model of heart failure.
Rademaker MT; Fitzpatrick MA; Charles CJ; Richards AM; Nicholls MG; Espiner EA; Sybertz E
J Cardiovasc Pharmacol; 1996 Mar; 27(3):439-46. PubMed ID: 8907807
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of renal neutral endopeptidase in severe heart failure.
Knecht M; Pagel I; Langenickel T; Philipp S; Scheuermann-Freestone M; Willnow T; Bruemmer D; Graf K; Dietz R; Willenbrock R
Life Sci; 2002 Oct; 71(23):2701-12. PubMed ID: 12383878
[TBL] [Abstract][Full Text] [Related]
11. Long-term treatment with neutral endopeptidase inhibitor improves cardiac function and reduces natriuretic peptides in rats with chronic heart failure.
Maki T; Nasa Y; Yamaguchi F; Yoshida H; Mori M; Takada T; Horikawa E; Okano K; Takeo S
Cardiovasc Res; 2001 Aug; 51(3):608-17. PubMed ID: 11476752
[TBL] [Abstract][Full Text] [Related]
12. Effects of acute and chronic blockade of neutral endopeptidase with Sch 34826 on NaCl-sensitive hypertension in spontaneously hypertensive rats.
Jin H; Mathews C; Chen YF; Yang R; Wyss JM; Esunge P; Oparil S
Am J Hypertens; 1992 Apr; 5(4 Pt 1):210-8. PubMed ID: 1318053
[TBL] [Abstract][Full Text] [Related]
13. Combined endopeptidase inhibition and adrenomedullin in sheep with experimental heart failure.
Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
Hypertension; 2002 Jan; 39(1):93-8. PubMed ID: 11799085
[TBL] [Abstract][Full Text] [Related]
14. [Functional compartmentation of the endocrine action of cardiac natriuretic peptides].
Haloui M; Arnal JF; Pham I; Gonzalez W; Lyoussi B; Michel JB
Ann Endocrinol (Paris); 2000 Feb; 61(1):32-40. PubMed ID: 10790590
[TBL] [Abstract][Full Text] [Related]
15. Natriuretic and antialdosterone actions of chronic oral NEP inhibition during progressive congestive heart failure.
Martin FL; Stevens TL; Cataliotti A; Schirger JA; Borgeson DD; Redfield MM; Luchner A; Burnett JC
Kidney Int; 2005 May; 67(5):1723-30. PubMed ID: 15840018
[TBL] [Abstract][Full Text] [Related]
16. The role of neutral endopeptidase in dogs with evolving congestive heart failure.
Margulies KB; Barclay PL; Burnett JC
Circulation; 1995 Apr; 91(7):2036-42. PubMed ID: 7895362
[TBL] [Abstract][Full Text] [Related]
17. Effects of renal neutral endopeptidase inhibition on sodium excretion, renal hemodynamics and neurohormonal activation in patients with congestive heart failure.
Kimmelstiel CD; Perrone R; Kilcoyne L; Souhrada J; Udelson J; Smith J; de Bold A; Griffith J; Konstam MA
Cardiology; 1996; 87(1):46-53. PubMed ID: 8631044
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of neutral endopeptidase 3.4.24.11 in conscious dogs with pacing induced heart failure.
Seymour AA; Asaad MM; Lanoce VM; Fennell SA; Cheung HS; Rogers WL
Cardiovasc Res; 1993 Jun; 27(6):1015-23. PubMed ID: 8221758
[TBL] [Abstract][Full Text] [Related]
19. Acute and chronic neutral endopeptidase inhibition in rats with aortocaval shunt.
Willenbrock R; Scheuermann M; Höhnel K; Luft FC; Dietz R
Hypertension; 1996 Jun; 27(6):1259-66. PubMed ID: 8641733
[TBL] [Abstract][Full Text] [Related]
20. Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats.
Pham I; el Amrani AI; Fournié-Zaluski MC; Corvol P; Roques B; Michel JB
J Cardiovasc Pharmacol; 1992 Dec; 20(6):847-57. PubMed ID: 1282584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
